SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-63 Cr | ₹63 Cr | ₹0.58 Cr | ₹-2.45 Cr | ₹0.83 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-63 Cr |
| Mar2024 | ₹63 Cr |
| Mar2023 | ₹0.58 Cr |
| Mar2022 | ₹-2.45 Cr |
| Mar2017 | ₹0.83 Cr |
How is Net Cash Inflow / Outflow of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-63 Cr | Negative | |
| Mar2024 | ₹63 Cr | 10,713.84 | |
| Mar2023 | ₹0.58 Cr | Positive | |
| Mar2022 | ₹-2.45 Cr | Negative | |
| Mar2017 | ₹0.83 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,349.8 Cr | 2.2% | 9.4% | -20.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2.2% |
9.4% |
-20.4% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses